Awards/COOPERATIVE AGREEMENT (B)

$183,303,443

Department of Health and Human Services·Centers for Disease Control and Prevention

ACTION DATE2026-04-06·SOURCEUSASPENDING·SOURCE IDASST_NON_NU50CK000502_075

Award description

CK19-1904 EPIDEMIOLOGY AND LABORATORY CAPACITY FOR PREVENTION AND CONTROL OF EMERGING INFECTIOUS DISEASES (ELC)

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds epidemiology and laboratory capacity at DC government for emerging infectious disease prevention and control.

Sub-sectors

public-healthinfectious-disease-surveillanceepidemiology-capacity

Why this matters

Strengthens state/local disease surveillance infrastructure critical for early detection and response to pandemic threats.

Supply-chain signal

Drives demand for diagnostic equipment, laboratory reagents, and epidemiological software vendors serving public health agencies.

U.S.–China competition angle

Enhances U.S. domestic disease surveillance resilience independent of foreign laboratory or diagnostic supply chains.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002162.

Period of performance

Start

2019-08-01

End

2027-07-31

Status

activein 441 days

Recipient

Other awards from this recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier ASST_NON_NU50CK000502_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.